Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
90.58
-2.27 (-2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioNTech SE - American Depositary Shares
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
72
73
Next >
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
October 16, 2023
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
Via
Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
↗
October 16, 2023
Benzinga Bitcoin Spiked On False ETF Approval Rumor
Via
Benzinga
Topics
ETFs
Price Over Earnings Overview: BioNTech
↗
October 13, 2023
Via
Benzinga
A Look Into BioNTech Inc's Price Over Earnings
↗
October 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
↗
October 16, 2023
Via
Benzinga
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
↗
October 16, 2023
Pfizer cut about $9 billion from its sales expectations for Covid products this year.
Via
Investor's Business Daily
Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry
↗
October 05, 2023
Via
Benzinga
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
↗
October 16, 2023
Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves.
Via
Benzinga
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
↗
October 16, 2023
Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.
Via
Benzinga
Pfizer Cuts Annual Revenue Guidance By $9B Amid COVID-19 Vaccine Sales Slump, BioNTech Warns €900M Write-Offs
↗
October 16, 2023
Friday, Pfizer Inc (NYSE: PFE) slashed its full-year earnings and revenue guidance, citing decreasing demand for its
Via
Benzinga
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
October 16, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Cut Your Losses: Sell These 7 Weak Stocks Now
↗
October 16, 2023
You can't let weakness in a company or the market damage your portfolio. Avoid disappointing returns by moving on these stocks to sell.
Via
InvestorPlace
Is Novavax Stock a Buy Now?
↗
October 16, 2023
Is this company just a pandemic stock?
Via
The Motley Fool
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
October 16, 2023
From
BioNTech SE
Via
GlobeNewswire
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
October 16, 2023
From
BioNTech SE
Via
GlobeNewswire
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
↗
October 14, 2023
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...
Via
Talk Markets
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
↗
October 11, 2023
Vaccine revenue may have slipped but could still represent billions of dollars for these companies.
Via
The Motley Fool
7 Innovator Stocks Primed for Exceptional Growth
↗
October 10, 2023
These featured, inventive companies are not only transforming old sectors but also building bridges toward new ones.
Via
InvestorPlace
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
↗
October 09, 2023
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.
Via
Benzinga
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
↗
October 05, 2023
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Why Novavax Stock Fell Today
↗
October 04, 2023
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...
Via
Benzinga
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
↗
October 04, 2023
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.
Via
Benzinga
Short Sellers Are Betting Against Novavax (NVAX) Stock
↗
October 04, 2023
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.
Via
InvestorPlace
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
↗
October 03, 2023
The company can now join Pfizer and Moderna in launching an updated booster in the U.S.
Via
Investor's Business Daily
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
↗
October 03, 2023
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.
Via
Benzinga
Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19
↗
October 02, 2023
Discover the remarkable journey of Nobel Prize laureates Kariko and Weissman, who transformed medicine with mRNA vaccines, and the financial impact on Moderna and Pfizer stocks.
Via
Benzinga
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
↗
October 01, 2023
Analysts like these stocks for very good reasons.
Via
The Motley Fool
Why Pfizer and BioNTech Stocks Zoomed Higher Today
↗
September 29, 2023
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.
Via
The Motley Fool
Why CureVac Stock Plunged Today
↗
September 29, 2023
A German court temporarily suspended proceedings in CureVac's IP lawsuit against BioNTech.
Via
The Motley Fool
Topics
Lawsuit
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
September 28, 2023
From
BioNTech SE
Via
GlobeNewswire
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
